These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2573055

  • 1. Membrane receptors for peptides in experimental and human pancreatic cancers.
    Fekete M, Zalatnai A, Comaru-Schally AM, Schally AV.
    Pancreas; 1989; 4(5):521-8. PubMed ID: 2573055
    [Abstract] [Full Text] [Related]

  • 2. Presence of membrane binding sites for [D-TRP6]-luteinizing hormone-releasing hormone in experimental pancreatic cancer.
    Fekete M, Zalatnai A, Schally AV.
    Cancer Lett; 1989 May; 45(2):87-91. PubMed ID: 2567204
    [Abstract] [Full Text] [Related]

  • 3. Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia.
    Fekete M, Redding TW, Comaru-Schally AM, Pontes JE, Connelly RW, Srkalovic G, Schally AV.
    Prostate; 1989 May; 14(3):191-208. PubMed ID: 2471961
    [Abstract] [Full Text] [Related]

  • 4. Receptors for D-Trp6-luteinizing hormone-releasing hormone, somatostatin, and insulin-like growth factor I in MXT mouse mammary carcinoma.
    Srkalovic G, Szende B, Redding TW, Groot K, Schally AV.
    Proc Soc Exp Biol Med; 1989 Dec; 192(3):209-18. PubMed ID: 2574866
    [Abstract] [Full Text] [Related]

  • 5. Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone.
    Paz-Bouza JI, Redding TW, Schally AV.
    Proc Natl Acad Sci U S A; 1987 Feb; 84(4):1112-6. PubMed ID: 2881296
    [Abstract] [Full Text] [Related]

  • 6. Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin.
    Szende B, Zalatnai A, Schally AV.
    Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1643-7. PubMed ID: 2564204
    [Abstract] [Full Text] [Related]

  • 7. Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer.
    Fekete M, Wittliff JL, Schally AV.
    J Clin Lab Anal; 1989 Mar; 3(3):137-47. PubMed ID: 2569034
    [Abstract] [Full Text] [Related]

  • 8. Combination treatment of nitrosamine-induced pancreatic cancers in hamsters with analogs of LH-RH and a bombesin/GRP antagonist.
    Szepshazi K, Halmos G, Groot K, Schally AV.
    Int J Pancreatol; 1994 Mar; 16(2-3):141-9. PubMed ID: 7868940
    [Abstract] [Full Text] [Related]

  • 9. Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists.
    Szende B, Srkalovic G, Groot K, Lapis K, Schally AV.
    Cancer Res; 1990 Jun 15; 50(12):3716-21. PubMed ID: 2160323
    [Abstract] [Full Text] [Related]

  • 10. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV, Redding TW.
    Proc Natl Acad Sci U S A; 1987 Oct 15; 84(20):7275-9. PubMed ID: 2890164
    [Abstract] [Full Text] [Related]

  • 11. Detection and partial characterization of receptors for [D-Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma.
    Srkalovic G, Wittliff JL, Schally AV.
    Cancer Res; 1990 Mar 15; 50(6):1841-6. PubMed ID: 2155060
    [Abstract] [Full Text] [Related]

  • 12. Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.
    Kadar T, Redding TW, Ben-David M, Schally AV.
    Proc Natl Acad Sci U S A; 1988 Feb 15; 85(3):890-4. PubMed ID: 2893378
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Events that accompany tumor regression.
    Szende B, Srkalovic G, Schally AV, Lapis K, Groot K.
    Cancer; 1990 May 15; 65(10):2279-90. PubMed ID: 1971771
    [Abstract] [Full Text] [Related]

  • 14. Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160. Histological evidence of improvement.
    Zalatnai A, Schally AV.
    Int J Pancreatol; 1989 Mar 15; 4(2):149-60. PubMed ID: 2566638
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160.
    Milovanovic SR, Radulovic S, Groot K, Schally AV.
    Prostate; 1992 Mar 15; 20(4):269-80. PubMed ID: 1376910
    [Abstract] [Full Text] [Related]

  • 16. Effect of combination treatment with analogs of luteinizing hormone-releasing hormone (LH-RH) or somatostatin and 5-fluorouracil on pancreatic cancer in hamsters.
    Szepeshazi K, Lapis K, Schally AV.
    Int J Cancer; 1991 Sep 09; 49(2):260-6. PubMed ID: 1679045
    [Abstract] [Full Text] [Related]

  • 17. The concentration of LH-RH receptors in the nuclei of pancreatic cancer cells. Effect of (D-Trp6)LH-RH on tumor-bearing Syrian golden hamsters.
    Szende B, Csikós A, Szepeshazi K, Neill JD, Mulchahey JJ, Halmos G, Lapis K, Schally AV.
    Receptor; 1994 Sep 09; 4(4):201-7. PubMed ID: 7894336
    [Abstract] [Full Text] [Related]

  • 18. Treatment of N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analogue RC-160 microcapsules.
    Zalatnai A, Schally AV.
    Cancer Res; 1989 Apr 01; 49(7):1810-5. PubMed ID: 2564312
    [Abstract] [Full Text] [Related]

  • 19. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
    Radulovic S, Comaru-Schally AM, Milovanovic S, Schally AV.
    Pancreas; 1993 Jan 01; 8(1):88-97. PubMed ID: 8093555
    [Abstract] [Full Text] [Related]

  • 20. Presence and characteristics of receptors for [D-Trp6]luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer.
    Srkalovic G, Schally AV, Wittliff JL, Day TG, Jenison EL.
    Int J Oncol; 1998 Mar 01; 12(3):489-98. PubMed ID: 9472084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.